The FDA-approved device, FloPatch, examines blood flow in the carotid arteries and transmits the information to a secure iOS device. The manufacturer, Flosonics Medical, said the patch offers greater precision in intravenous fluid management compared to other blood flow and heart function measurement products.
For every 10 FloPatches used, a recently published study showed 4 in 5 patients will avoid potentially dangerous fluid overload in the emergency department, the release said.
Sutter clinicians will soon use the patch at the system’s Eden Medical Center in Castro Valley, Calif., and the California Pacific Medical Center in San Francisco at its Van Ness, Davies and Mission Bernal campuses.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.